Edward Rogers

Edward Rogers

Ballard Spahr LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Speed of Pharmaceutical Innovation at Stake in N.Y. Antitrust Lawsuit

A pharmaceutical firm’s ability to efficiently produce and promote a better treatment for Alzheimer’s disease lies at the center of an antitrust lawsuit pending before the U.S. Court of Appeals for the Second Circuit. In...more

1/22/2015 - Actavis Inc. Antitrust Litigation Appeals Generic Drugs Injunctions Pharmaceutical Pharmaceutical Manufacturers Prescription Drugs Product Hopping

Updates from the Fannie Mae DUS Multifamily front

In the past month, Fannie Mae has issued preferred equity guidance and has updated its adjustable rate loan document forms to account for the change in LIBOR administrator. - Preferred Equity Requirements: On...more

4/25/2014 - Fannie Mae Libor Preferred Shares

Supreme Court Chooses Middle Ground in Assessing Reverse Payment Settlements

The U.S. Supreme Court issued its much-anticipated opinion today in FTC v. Actavis, Inc., ruling that so-called “reverse payment” patent settlements between innovator and generic pharmaceutical manufacturers that are...more

6/18/2013 - Anti-Competitive FTC FTC v Actavis Generic Hatch-Waxman Patents Pharmaceutical Reverse Payment Settlement Agreements SCOTUS

3 Results
|
View per page
Page: of 1